This investment will enable the company to finalize the technical development of its solution and accelerate the industrialization of its production (...)
On October 22, 2025, the biopharmaceutical group Ipsen announced that it had entered into a definitive agreement to acquire ImCheck Therapeutics, a (...)
Plasseraud IP s radostí oznamuje, že Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud a Ina Schreiber byli znovu oceněni jako přední patentoví (...)
Společnost Oculis byla založena v prosinci 2017 a je globální biofarmaceutickou společností specializující se na oční a neurooftalmologické choroby, (...)
Following its successful expansion into Munich, Shanghai, Prague, Madrid and Alicante, Plasseraud IP is pleased to announce the opening of its new (...)
At Plasseraud IP, we are pleased to introduce our Patent Landscape Analysis service, a powerful tool designed to provide you with valuable insights (...)
Plasseraud IP is delighted to announce that Cyra Nargolwalla, Bertrand Loisel and Eric Burbaud, Managing Partners, have been recognized as leading (...)
Plasseraud IP is delighted to announce the appointment of Charlotte Leleu, Charlotte Montaud and Nathalie Wajs as “Rising Stars 2024” by Managing IP (...)
Plasseraud IP is pleased to announce the ranking of Cyra Nargolwalla and Nadine Rocaboy as internationally renowned IP experts in the IAM Strategy (...)
As of September 1, 2024, Romania has officially become the 18th member of the Unitary Patent (UP) system and the Unified Patent Court (UPC). From (...)
紹介資料を開く